Go to our new-look site, it combines the Biotechnology and Science Learning Hubs with a new look and new functionality. This is our legacy site and is no longer maintained.

Skip to page content

Site navigation

Leukaemia vaccine research

15 Oct, 2009

Robert Weinkove explains why he is developing a new immunotherapy for treating leukaemia that would stimulate the patient’s own immune system to fight the cancerous cells.

Listen to audio: Leukaemia vaccine research

Duration: 22:00

Chronic lymphocytic leukaemia is the most common leukaemia in New Zealand. Currently, the only treatment is chemotherapy, which is often ineffective, or a bone marrow transplant.

Robert Weinkove is a haematologist working at Wellington Hospital and the Malaghan Institute of Medical Research. Here, he explains how a vaccine could be used to treat cancer.

Programme details: Our Changing World


Return to top